LEMON HEALTHCARE Co.: debt-to-equity, ROE and more
KOSDAQ, Legal name LEMON HEALTHCARE Co.
Latest figures are the FY2025 separate summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 373.6%
- Equity ratio
- 21.1%
- ROE
- -97.3%
- Op. margin
- -4.2%
- Rev. growth
- 7.2%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 1 straight year.
- Total equity is below paid-in capital: partial impairment (자본잠식), rate 61.8%.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 117.7% | 45.9% | -196.0% | -155.6% | n/a |
| FY2022 separate | 59.6% | 62.7% | -100.8% | -146.0% | 12.2% |
| FY2023 separate | 227.7% | 30.5% | -260.9% | -88.2% | 42.2% |
| FY2024 separate | n/a | -287.5% | n/a | 0.9% | 145.8% |
| FY2025 separate | 373.6% | 21.1% | -97.3% | -4.2% | 7.2% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩3.8B | ₩4.3B | ₩6.1B | ₩14.9B | ₩16.0B |
| Operating profit | -₩5.9B | -₩6.2B | -₩5.3B | ₩126.6M | -₩662.8M |
| Pre-tax income | -₩5.9B | -₩6.1B | -₩5.3B | -₩2.9B | -₩2.1B |
| Net income | -₩5.9B | -₩6.1B | -₩5.3B | -₩2.9B | -₩2.1B |
| Total assets | ₩6.6B | ₩9.7B | ₩6.6B | ₩10.8B | ₩10.2B |
| Total liabilities | ₩3.6B | ₩3.6B | ₩4.6B | ₩42.0B | ₩8.1B |
| Total equity | ₩3.0B | ₩6.1B | ₩2.0B | -₩31.2B | ₩2.2B |
| Paid-in capital | ₩4.8B | ₩5.3B | ₩5.5B | ₩4.3B | ₩5.6B |
| Debt/equity (source value) | 117.7% | 59.6% | 227.7% | 0.0% | 373.6% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2017-06-30
- Listed
- 26/07/06
- Employees
- n/a
- Auditor
- n/a
- Audit opinion
- n/a
- Corporate reg. no.
- 1101116446995
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 레몬헬스케어Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.